These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9080424)
21. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. Slovin H; Abeles M; Vaadia E; Haalman I; Prut Y; Bergman H J Neurophysiol; 1999 Feb; 81(2):858-74. PubMed ID: 10036286 [TBL] [Abstract][Full Text] [Related]
22. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Pifl C; Schingnitz G; Hornykiewicz O Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053 [TBL] [Abstract][Full Text] [Related]
23. MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine. Mingazov ER; Khakimova GR; Kozina EA; Medvedev AE; Buneeva OA; Bazyan AS; Ugrumov MV Mol Neurobiol; 2018 Apr; 55(4):2991-3006. PubMed ID: 28456940 [TBL] [Abstract][Full Text] [Related]
24. Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice. Khakimova GR; Kozina EA; Buneeva OA; Aksenova LN; Medvedev AE; Ugryumov MV Bull Exp Biol Med; 2015 Aug; 159(4):456-8. PubMed ID: 26388575 [TBL] [Abstract][Full Text] [Related]
25. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Jenner P; Marsden CD J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760 [TBL] [Abstract][Full Text] [Related]
26. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Guridi J; Herrero MT; Luquin MR; Guillén J; Ruberg M; Laguna J; Vila M; Javoy-Agid F; Agid Y; Hirsch E; Obeso JA Brain; 1996 Oct; 119 ( Pt 5)():1717-27. PubMed ID: 8931592 [TBL] [Abstract][Full Text] [Related]
27. Neurochemical findings in the MPTP model of Parkinson's disease. Schmidt N; Ferger B J Neural Transm (Vienna); 2001; 108(11):1263-82. PubMed ID: 11768626 [TBL] [Abstract][Full Text] [Related]
28. MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus. Sy HN; Wu SL; Wang WF; Chen CH; Huang YT; Liou YM; Chiou CS; Pawlak CR; Ho YJ Pharmacol Biochem Behav; 2010 Apr; 95(2):158-65. PubMed ID: 20064549 [TBL] [Abstract][Full Text] [Related]
29. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease]. Lange KW Fortschr Neurol Psychiatr; 1989 Apr; 57(4):142-8. PubMed ID: 2656447 [TBL] [Abstract][Full Text] [Related]
30. Protective role of 6-Hydroxy-1-H-Indazole in an MPTP-induced mouse model of Parkinson's disease. Xiao-Feng L; Wen-Ting Z; Yuan-Yuan X; Chong-Fa L; Lu Z; Jin-Jun R; Wen-Ya W Eur J Pharmacol; 2016 Nov; 791():348-354. PubMed ID: 27614126 [TBL] [Abstract][Full Text] [Related]
31. Cell survival patterns in the pedunculopontine tegmental nucleus of methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys and 6OHDA-lesioned rats: evidence for differences to idiopathic Parkinson disease patients? Heise CE; Teo ZC; Wallace BA; Ashkan K; Benabid AL; Mitrofanis J Anat Embryol (Berl); 2005 Nov; 210(4):287-302. PubMed ID: 16237536 [TBL] [Abstract][Full Text] [Related]
32. Cerebral metabolic effects of monoamine oxidase inhibition in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine acutely treated monkeys. Palombo E; Porrino LJ; Crane AM; Bankiewicz KS; Kopin IJ; Sokoloff L J Neurochem; 1991 May; 56(5):1639-46. PubMed ID: 2013759 [TBL] [Abstract][Full Text] [Related]
33. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. Pifl C; Nanoff C; Schingnitz G; Schütz W; Hornykiewicz O J Neurochem; 1992 Jun; 58(6):1997-2004. PubMed ID: 1349341 [TBL] [Abstract][Full Text] [Related]
34. Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease. Fifel K; Dkhissi-Benyahya O; Cooper HM Chronobiol Int; 2013 Jul; 30(6):741-55. PubMed ID: 23758587 [TBL] [Abstract][Full Text] [Related]
36. Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Hare DJ; Adlard PA; Doble PA; Finkelstein DI Metallomics; 2013 Feb; 5(2):91-109. PubMed ID: 23322189 [TBL] [Abstract][Full Text] [Related]
37. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice. Togashi K; Hasegawa M; Nagai J; Tonouchi A; Masukawa D; Hensley K; Goshima Y; Ohshima T Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127 [TBL] [Abstract][Full Text] [Related]
38. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Doudet D; Gross C; Lebrun-Grandié P; Bioulac B C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601 [TBL] [Abstract][Full Text] [Related]
39. [The effect of amiridin on the MPTP-induced Parkinson-like syndrome in monkeys]. Burov IuV; Metkalova SE; Kustov AE; Petrov GV; Shul'govskiĭ VV Biull Eksp Biol Med; 1992 Nov; 114(11):495-7, 494. PubMed ID: 1290822 [TBL] [Abstract][Full Text] [Related]
40. Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Starr PA; Wichmann T; van Horne C; Bakay RA Cell Transplant; 1999; 8(1):37-45. PubMed ID: 10338274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]